ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC)

The Estrogen Pathway: Estrogen Receptor-α, Progesterone Receptor, and Estrogen Receptor-β Expression in Radical Cystectomy Urothelial Cell Carcinoma Specimens

(2015) Winston Tan et al.   Clinical Genitourinary Cancer

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

(2014) Woonyoung Choi et al.   CANCER CELL

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Prognostic role of HER2 expression in bladder cancer: a systematic review and meta-analysis

(2014) Junjie Zhao et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Comprehensive molecular characterization of urothelial bladder carcinoma

(2014)   NATURE

Introduction and First Clinical Application of a Simplified Immunohistochemical Validation System Confirms Prognostic Impact of KI-67 and CK20 for Stage T1 Urothelial Bladder Carcinoma: Single-Center Analysis of Eight Biomarkers in a Series of Three Hundred Six Patients

(2013) Wolfgang Otto et al.   Clinical Genitourinary Cancer

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

(2013) Marko Babjuk et al.   EUROPEAN UROLOGY

Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer

(2013) Gopa Iyer et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of oestrogen receptors in bladder cancer development

(2013) Iawen Hsu et al.   Nature Reviews Urology

Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer

(2013) Lujia Wang et al.   TUMOR BIOLOGY

Prognostic Factors of ‘High-Grade' Ta Bladder Cancers according to the WHO 2004 Classification: Are These Equivalent to ‘High-Risk' Non-Muscle-Invasive Bladder Cancer?

(2013) Paolo Gontero et al.   UROLOGIA INTERNATIONALIS

A Molecular Taxonomy for Urothelial Carcinoma

(2012) G. Sjodahl et al.   CLINICAL CANCER RESEARCH

Her2 amplification distinguishes a subset of non-muscle-invasive bladder cancers with a high risk of progression

(2012) Paul Chih-Hsueh Chen et al.   JOURNAL OF CLINICAL PATHOLOGY

Raloxifene Inhibits Growth of RT4 Urothelial Carcinoma Cells via Estrogen Receptor-Dependent Induction of Apoptosis and Inhibition of Proliferation

(2012) Kristi L. Hoffman et al.   Hormones & Cancer

The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer

(2010) Wolfgang Otto et al.   BJU INTERNATIONAL

Roles of estrogen receptor   and   in modulating urothelial cell proliferation

(2008) J. Teng et al.   ENDOCRINE-RELATED CANCER